to page content
to site navigation
The Foundation's primary site.
Global news, events, and resources.
The national learning program for entrepreneurs.
A new approach to developing the next generation of high-growth firms.
Access to university research and innovation.
The Kauffman Foundation's charter school serving Kansas City.
Encouraging the aspirations of young people.
The platform for business plan competitions.
College preparation and access for urban youth in Kansas City.
A guide to Kauffman Foundation and partner resources, for aspiring entrepreneurs.
News and announcements from the Foundation.
From our vice president of Entrepreneurship.
From our vice president of Advancing Innovation.
News from Global Entrepreneurship Week
News about this education program for entrepreneurs.
Tweets for the eMed Community at Entrepreneurship.org
News from the Kauffman Labs program.
From our business plan competition service.
Contribute to the community seeking to improve entrepreneurship and innovation measurement.
A look at entrepreneurship from the Kauffman Foundation's Thom Ruhe.
Tracks research and policies that are accelerating economic growth and changing the world.
Brings to light various policies and initiatives to advance innovation and drive economic growth.
A selection of our videos
Take our video and audio with you.
Explore many of our publications.
Join the discussion on our LinkedIn site.
Join us on Google's social service.
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
Readers of this blog know that we credit the greater availability of data on entrepreneurship for the healthy race to build the best start-up ecosystem that is going on around the globe. By revealing weak areas in a country’s entrepreneurship ecosystem and enabling cross-country comparisons, data can yield important implications for economic and regulatory policy.
Is the third time really the charm? A bipartisan group—U.S. Senators Jerry Moran (R-Kan.) and Mark Warner (D-Va.), along with Chris Coons (D-Del.) and Roy Blunt (R-Mo.)—recently introduced Startup Act 3.0, aiming to revitalize the economy by making it easier to start and grow new firms.
Each day, Innovation Daily checks the pulse of global innovation--courtesy of Innovation America. Here, we take a look at a handful of relevant stories it compiled last week.
More than 20 years ago, MTV launched the reality TV genre by throwing a group of strangers together in the same house to live and work. The show started in New York and has been filmed in 27 cities since. While Kansas City never had a chance to “find out what happens when people stop being polite... and start getting real” it is getting something even better—and certainly much less annoying—the Brad Feld’s KC Fiberhouse.
Thousands of people from 135 countries have already confirmed their participation for next month’s week-long Global Entrepreneurship Congress (GEC) and festival in Rio de Janeiro. As chair of the GEC for the past few years, I have witnessed the emergence of this global platform for collaboration among entrepreneurs, their investors and national leaders held outside the United States. So what happens at the GEC?
Clear your schedule for the rest of the week if you plan on tracking all of the relevant congressional committee hearings. The “House side” of Capitol Hill is particularly busy with hearings on the budget and monetary policy with Federal Reserve chair Ben Bernanke, the impact of e-verity on immigration, broadband stimulus, regulatory hurdles and more.
Because life sciences entrepreneurship thrives on harnessing new technologies, spurring innovation, and growing companies, the Kauffman Foundation met in 2003 with the Panel of Advisors on the Life Sciences to help advance those goals.
Dr. Todd O’Brien has additional challenges beyond those encountered by most startup life science CEOs. The 48-year-old podiatrist still sees patients even while developing his latest innovation: an electronic tuning fork for measuring diabetes-related nerve damage in people’s feet. He's also building his company in Orono, Maine - far from any major healthcare hub.
DioGenix, in Gaithersburg, Md., was founded in 2009 after CEO Larry Tiffany and his senior management team saw a clear clinical need: monitoring disease progression of multiple sclerosis (MS). Tiffany has an extensive background in biotech, as an IP attorney, and as a senior executive at small and mid-size biotech companies. Before DioGenix, he was senior vice president and general manager of genomics for another genomics research company, Gene Logic.
It’s a cancer immunologist’s dream to discover a safe and effective way to coax the body’s own immune system into waging war against invading cancer cells. Building a startup company around that finding, though, is definitely not every scientist’s forte. For Gary W. Wood, making the leap from laboratory to C-suite seemed like the next logical step.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.
